Systematic review of available evidence on 11 high-priced inpatient orphan drugs

BACKGROUND: Attention for Evidence Based Medicine (EBM) is growing, but evidence for orphan drugs is argued to be limited and inferior. This study systematically reviews the available evidence on clinical effectiveness, cost-effectiveness and budget impact for orphan drugs. METHODS: A systematic rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanters, Tim A, de Sonneville-Koedoot, Caroline, Redekop, W Ken, Hakkaart, Leona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751719/
https://www.ncbi.nlm.nih.gov/pubmed/23947946
http://dx.doi.org/10.1186/1750-1172-8-124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751719/
https://www.ncbi.nlm.nih.gov/pubmed/23947946
http://dx.doi.org/10.1186/1750-1172-8-124

Ejemplares similares